Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2004
03/04/2004US20040044222 New substituted indolinones, preparation thereof and their use as pharmaceutical compositions
03/04/2004US20040044216 Reacting 5-methylnicotinic acid with alkyl chloroformate
03/04/2004US20040044215 Crystallization, filtration; neurokinins receptor antagonist
03/04/2004US20040044211 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
03/04/2004US20040044203 Anticancer agents
03/04/2004US20040044201 Bone disorders; osteoporosis; oral diseases; antiarthritic agents
03/04/2004US20040044057 5- substituted tetralones as inhibitors of ras farnesyl trransferase
03/04/2004US20040044053 Antitumor agents; kinase inhibitor
03/04/2004US20040044051 Cannabinoid receptor agonists
03/04/2004US20040044042 Process for preparing heterocyclo-alkylsulfonyl pyrazole derivatives
03/04/2004US20040044041 2-(Biarylalkyl)amino-3-(cyanoalkanoylamino)pyridine derivatives
03/04/2004US20040044032 Using an (imidazol-5-yl-)methyl-2-quinolinone compound
03/04/2004US20040044031 Controlling appetite; dietetics; sleep disorders
03/04/2004US20040044030 Cardiovascular disorders; antiarrhythmia agents
03/04/2004US20040044029 Azabicyclic compounds are central nervous system active agents
03/04/2004US20040044017 Tetrahydropyridines
03/04/2004US20040044009 Drug abuse; cental nervous system disorders; cognition activators
03/04/2004US20040044007 Pyschological and central nervous system diosrders; neurolptics; side effect reduction
03/04/2004US20040044004 Calcium channel inhibitors comprising benzhydril spaced from piperazine
03/04/2004US20040044003 Therapeutic agents useful for treating pain
03/04/2004US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents
03/04/2004US20040044000 Cardiovascular disorders; antiarthritic agents; inflammatory bowel disorders; vision defects; respiratory system disorders
03/04/2004US20040043999 Phthalazine derivatives as phosphodiesterase 4-inhibitors
03/04/2004US20040043994 Antitumor agents, endometriosis, vision defects, antiarthritic agents, angiogenesis inhibitors
03/04/2004US20040043989 Therapy for drug resistant bacteria; topoisomerase inhibitor
03/04/2004US20040043986 Cardiovascular disorders; inflammatory bowel disorders; antiarthritic agents; skin disorders; vision defects; osteoporosis
03/04/2004US20040043984 3,4-Dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors
03/04/2004US20040043983 Cardiovascular disorders; antiarthritic agents; inflammatory bowel disorders; vision defects; respiratory system disorders
03/04/2004US20040043979 Antiarthritic agents; cardiovascular disorders; imflammatory bowel disorders; skin disordfers; vision disorders
03/04/2004US20040043426 Using "tethering" where potential ligands are covalently bonded or "tethered" to a target and subsequently identified
03/04/2004US20040043247 Organic electroluminescence devices using pyrazolo [3,4B] quinoxaline derivatives
03/04/2004US20040040840 Controller for redox system
03/04/2004DE10238742A1 New N-(maleimidyl- or thiohydantoinyl-alkyl)-piperazine derivatives, are androgen receptor destabilizers and/or inhibitors useful e.g. for treating prostate carcinoma or hyperplasia
03/04/2004DE10238725A1 New heterocyclyl-substituted 2-(difluorobutenyl-sulfanyl)-pyrimidine derivatives, useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents
03/04/2004DE10238045A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical
03/04/2004CA2501849A1 2-thio-substituted imidazole derivatives and their use in treating diseases associated with a disorder of the immune system
03/04/2004CA2496464A1 Agent for prevention and/or treatment of itching
03/04/2004CA2496246A1 Pyrrole based inhibitors of glycogen synthase kinase 3
03/04/2004CA2496197A1 5-substituted-2-arylpyrazines as modulators of crf receptors
03/04/2004CA2495682A1 Method for the prevention and/or treatment of atherosclerosis
03/04/2004CA2495597A1 Novel phenanthridines
03/04/2004CA2495050A1 Two-photon absorption heteroaromatic chromophores and compositions thereof
03/04/2004CA2494650A1 Pyridazinone-derivatives as pde4 inhibitors
03/04/2004CA2494643A1 Piperidine-n-oxide-derivatives
03/04/2004CA2494634A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors
03/04/2004CA2494263A1 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
03/04/2004CA2494164A1 Pyridyl substituted heterocycles useful for treating or preventing hcv infection
03/03/2004EP1394152A1 2-iminoimidazole derivatives (1)
03/03/2004EP1394150A1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists
03/03/2004EP1392776A2 Acridone derivatives as labels for fluorescence detection of target materials
03/03/2004EP1392690A2 Novel processes for the preparation of adenosine compounds and intermediates thereto
03/03/2004EP1392682A2 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
03/03/2004EP1392681A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
03/03/2004EP1392680A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
03/03/2004EP1392679A1 Novel 1-amidomethylcarbonyl-piperidine derivatives, method and intermediate products for the production thereof and medicament containing said compounds
03/03/2004EP1392678A2 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof
03/03/2004EP1392677A2 Chiral broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
03/03/2004EP1392663A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
03/03/2004EP1392662A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
03/03/2004EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents
03/03/2004EP1392655A2 Potassium channel openers
03/03/2004EP1392654A1 Integrin antagonists
03/03/2004EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives
03/03/2004EP1392363A2 Compositions and uses of mglur5 antagonists
03/03/2004EP1392315A1 Methods of treating alzheimer's disease
03/03/2004EP1392310A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
03/03/2004EP1392309A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
03/03/2004EP1392306A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases
03/03/2004EP1392302A1 5-substituted-2-arylpyridines as crf1 modulators
03/03/2004EP1392291A2 Tripeptidyl peptidase inhibitors
03/03/2004EP1392219A2 Substituted n'-(arylcarbonyl)-benzhydrazides, n'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apotosis and the use thereof
03/03/2004EP1045839B1 Novel amines as pharmaceutical agents
03/03/2004EP1017692B1 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
03/03/2004EP0998460B1 Novel tetrazole derivatives
03/03/2004EP0882714B1 Substituted vinylpyridine derivatives and drugs containing the same
03/03/2004EP0865430B1 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists
03/03/2004EP0853617B1 Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives
03/03/2004EP0788500B1 PROCESSES AND INTERMEDIATES FOR PREPARING 5,7-DIHYDRO-3- 2- 1-BENZYLPIPERIDIN-4-YL ETHYL]-6H-PYRROLO- 4,5-f]-1,2-BENZISOXAZOL-6-ONE
03/03/2004EP0636028B1 Self-assembling polynucleotide delivery system comprising an amphiphatic cationic peptide
03/03/2004CN1479737A Ethanolates of sodium-proton exchanger protein type-1 inhibitor
03/03/2004CN1479728A Pexoxisome proliferator activated receptor alpha agonists
03/03/2004CN1479727A Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor
03/03/2004CN1479724A Pyridione derivatives for tretment of atherosclerosis
03/03/2004CN1479722A Guanidine and amidine derivatives as factor Xa inhibitors
03/03/2004CN1479618A Treatment of sexual dysfunction using boonbesin antagonist
03/03/2004CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor
03/03/2004CN1140524C 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders
03/03/2004CN1140513C Phenylsulphenyl ureas, process for their preparation and their use as herbicides and plant-growth regulators
03/03/2004CN1140511C Amino piperidine derivatives as integrin alphabeta 3 antagonists
03/02/2004US6699989 Antiviral and antimicrobial guanidine or biguanidine derivatives
03/02/2004US6699899 Substituted acylhydroxamic acids and method of reducing TNFα levels
03/02/2004US6699890 Phosphodiesterase 4 inhibitors
03/02/2004US6699888 Antiinflammatory
03/02/2004US6699887 Administering a therapeutically effective amount of a pyrrazole sulfide or ether compound to treat the human immunodeficiency virus infection
03/02/2004US6699883 Antibiotics, bactericides, antitumor
03/02/2004US6699881 Thiol compounds, their production and use
03/02/2004US6699880 Substituted imidazolidinone derivatives
03/02/2004US6699879 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
03/02/2004US6699878 Imidazonaphthyridines
03/02/2004US6699872 N-substituted urea inhibitors of farnesyl-protein transferase